Clinical Trials Browser

Castration Resistant Metastatic Prostate Cancer × enzalutamide × Genitourinary × Clear all

NCT04363164 2025-07-14

Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

Phase 2 Recruiting

Castration Resistant Metastatic Prostate Cancer

NCT02286921 2020-11-06

Transformer

Phase 2 Completed

222 enrolled 25 charts

Castration Resistant Metastatic Prostate Cancer